Glyn Edwards talks about cancer drug development at Antisoma. Interview by Ulrike Knies-Bamforth and Dan Huke.
We're an exclusively oncology development-focused company; we've put together a portfolio of projects, which are rather different from each other, which is our way of diversifying the systemic risk out of the portfolio.
Edwards
Glyn
G
Antisoma, West Africa House, Hanger Lane, London, W5 3QR, UK.
D000970:Antineoplastic Agents / Q000737:chemistry* / Q000627:therapeutic use; D035843:Biomedical Research; D002986:Clinical Trials as Topic; D004345:Drug Industry / Q000458:organization & administration*; D009369:Neoplasms / Q000188:drug therapy*; D009937:Organizational Objectives
D000970:Antineoplastic Agents